Liberty Law Team(@LibertyLawTeam) 's Twitter Profile Photo

Unlocking the language of law one idiom at a time. When it comes to your case, we transform uncertainties into open-and-shut certainties. Trust Liberty Law Team for clarity in every legal journey. ⚖️✨

Unlocking the language of law one idiom at a time. When it comes to your case, we transform uncertainties into open-and-shut certainties. Trust Liberty Law Team for clarity in every legal journey. ⚖️✨ #LegalIdioms #ClearOutcomes #libertylawteam
account_circle
Martina Amiguet(@amiguet_m) 's Twitter Profile Photo

✅ Happy to hear about today in : In 👤👤non-suitable for statins, ⬇️13%
4️⃣MACE in , compared to placebo.
✏️Note 70% was secondary prevention and 48%👩🏼‍🦰👩🏼👩🏽

✅ Happy to hear about #bempedoic today in #ACC23:  In 👤👤non-suitable for statins, ⬇️13%
4️⃣MACE in #CLEAROutcomes, compared to placebo.
✏️Note 70% was secondary prevention and 48%👩🏼‍🦰👩🏼👩🏽
account_circle
Heather M. Johnson, MD, MMM, FAHA, FACC, FASPC(@DrHeatherJohn) 's Twitter Profile Photo

Exciting news announced at from for primary prevention! 59% female, 66% with diabetes, significant MACE reduction
jamanetwork.com/journals/jama/…

Exciting news announced at #ADA2023 from #CLEAROutcomes for primary prevention! 59% female, 66% with diabetes, significant MACE reduction
 jamanetwork.com/journals/jama/…
account_circle
Primastcar(@primastcar) 's Twitter Profile Photo

🗓 👉 05/03/2023

📣📣‼️Repasamos en 5 Tuits ‼️

👉 Abrimos mini 🧵y avanzamos los resultados ClearOutcomes

✅ AcBempedoico en intolerantes a estatinas

💚⬇️ MACE CV: IAM, REVASC🫀

🤔 Efecto neutro en mortalidad

🤔 Mas eficaz en Prevención 1aria

🗓 👉 05/03/2023

📣📣‼️Repasamos en 5 Tuits #LaSemanaenCardioTwitter ‼️

👉 Abrimos mini 🧵y avanzamos los resultados #ACC23 ClearOutcomes

✅ AcBempedoico en intolerantes a estatinas

💚⬇️ MACE CV: IAM, REVASC🫀

🤔 Efecto neutro en mortalidad

🤔 Mas eficaz en Prevención 1aria
account_circle
𝕀nstituto ℂ𝕠𝕣𝕧𝕚𝕝𝕦𝕕(@icorvilud) 's Twitter Profile Photo

In selected high/very high CV risk population:
✅Representative ♀️ sample
❌ almost 50% of prevalence
❌ basal LDLc 139 mg/dl

✍️CLEARLy beneficial outcomes
BUT
✍️ CLEARLy CV prevention failure in daily practice

In #CLEAROutcomes selected high/very high CV risk population:
✅Representative ♀️ sample
❌ almost 50% of #diabetes prevalence
❌ basal LDLc 139 mg/dl

✍️CLEARLy beneficial outcomes 
BUT
✍️ CLEARLy CV prevention failure in daily practice
#Acc23 #lasectelleva #WCCCardio #bempedoic
account_circle
Henry Han(@HanCardiomd) 's Twitter Profile Photo

The trial showed that acid improves long-term CV outcomes and effectively reduces -C compared with placebo among patients with either established or who have a high risk for it, and with intolerance to therapy

Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦

The #CLEAROutcomes trial showed that #bempedoic acid improves long-term CV outcomes and effectively reduces #LDL-C compared with placebo among patients with either established #ASCVD or who have a high risk for it, and with intolerance to #statin therapy

#ACC23 @DrMarthaGulati…
account_circle